Cancer as a System Dysfunction
暂无分享,去创建一个
[1] Y. Lou,et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges , 2018, Journal of Hematology & Oncology.
[2] O. Pavlov,et al. Farmers, bandits and soldiers: a generic system for addressing peace agendas , 2013 .
[3] Khalid Saeed,et al. The dynamics of economic growth and political instability in developing countries , 1986 .
[4] D. Gleason,et al. Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.
[5] A. Drakaki,et al. To treat or not to treat: Patient exclusion in immune oncology clinical trials due to preexisting autoimmune disease , 2019, Cancer.
[6] J. Boehm,et al. Age and cancer risk: a potentially modifiable relationship. , 2014, American journal of preventive medicine.
[7] Samuel F. Bakhoum,et al. Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.
[8] K. Saeed,et al. Dynastic cycle : A generic structure describing resource allocation in political economies , markets and firms January , 2006 .
[9] Sarah A Heerboth,et al. Drug Resistance in Cancer: An Overview , 2014, Cancers.
[10] Lotfi A. Zadeh,et al. General System Theory , 1962 .
[11] M. Pittman,et al. Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence , 2019, Proceedings of the National Academy of Sciences.
[12] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[13] Kimberly M. Thompson,et al. Using system dynamics to develop policies that matter: global management of poliomyelitis and beyond , 2008 .
[14] R. Bast,et al. CRITICAL REVIEW OF PREVIOUSLY REPORTED ANIMAL STUDIES OF TUMOR IMMUNOTHERAPY WITH NON‐SPECIFIC IMMUNOSTIMULANTS , 1976, Annals of the New York Academy of Sciences.
[15] Jay W. Forrester,et al. System dynamics, systems thinking, and soft OR , 1994 .
[16] E. Montecino-Rodriguez,et al. Causes, consequences, and reversal of immune system aging. , 2013, The Journal of clinical investigation.
[17] D. Klassen,et al. The OPTN Deceased Donor Potential Study: Implications for Policy and Practice , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] Khalid Saeed,et al. Maintaining professional competence in innovation organizations , 1998 .
[19] J. Locasale,et al. The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.
[20] N. Weidner,et al. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors , 2004, Breast Cancer Research and Treatment.